These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33672561)

  • 41. SARS-CoV2 vaccines: Slow is fast.
    Green DR
    Sci Adv; 2020 Jul; 6(28):eabc7428. PubMed ID: 32923602
    [No Abstract]   [Full Text] [Related]  

  • 42. Physical interventions to interrupt or reduce the spread of respiratory viruses: Summary of a Cochrane review.
    Kwak J; Susan Wieland L
    Explore (NY); 2021; 17(3):277-278. PubMed ID: 33726953
    [No Abstract]   [Full Text] [Related]  

  • 43. Physical interventions to interrupt or reduce the spread of respiratory viruses - resource use implications: a systematic review.
    Lee K; Shukla V; Clark M; Mierzwinski-Urban M; Pessoa-Silva C; Conly J
    CADTH Technol Overv; 2012; 2(3):e2302. PubMed ID: 23002380
    [No Abstract]   [Full Text] [Related]  

  • 44. Rhamnolipid Micellization and Adsorption Properties.
    Zhang Y; Placek TL; Jahan R; Alexandridis P; Tsianou M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biosurfactants in the sustainable eradication of SARS COV-2 from the environmental surfaces.
    Raza ZA; Shahzad Q; Rehman A; Taqi M; Ayub A
    3 Biotech; 2022 Oct; 12(10):273. PubMed ID: 36101547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
    Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
    J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial Compounds from Microorganisms.
    Amaning Danquah C; Minkah PAB; Osei Duah Junior I; Amankwah KB; Somuah SO
    Antibiotics (Basel); 2022 Feb; 11(3):. PubMed ID: 35326749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs.
    Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
    bioRxiv; 2021 Oct; ():. PubMed ID: 34729559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19.
    Daverey A; Dutta K; Joshi S; Daverey A
    Bioengineered; 2021 Dec; 12(2):9550-9560. PubMed ID: 34709115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent Advances in Biomedical, Therapeutic and Pharmaceutical Applications of Microbial Surfactants.
    Ceresa C; Fracchia L; Fedeli E; Porta C; Banat IM
    Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33808361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses.
    Wood A; Payne D
    J Hosp Infect; 1998 Apr; 38(4):283-95. PubMed ID: 9602977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is wearing a face mask safe for people with epilepsy?
    Asadi-Pooya AA; Cross JH
    Acta Neurol Scand; 2020 Oct; 142(4):314-316. PubMed ID: 32654134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV2 in Different Body Fluids, Risks of Transmission, and Preventing COVID-19: A Comprehensive Evidence-Based Review.
    Kutti-Sridharan G; Vegunta R; Vegunta R; Mohan BP; Rokkam VRP
    Int J Prev Med; 2020; 11():97. PubMed ID: 33042494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of Environment-Friendly Rhamnolipids against Transmission of Enveloped Viruses Like SARS-CoV2.
    Jin L; Black W; Sawyer T
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium
    Giugliano R; Buonocore C; Zannella C; Chianese A; Palma Esposito F; Tedesco P; De Filippis A; Galdiero M; Franci G; de Pascale D
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The European tiered approach for virucidal efficacy testing - rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseases.
    Eggers M; Schwebke I; Suchomel M; Fotheringham V; Gebel J; Meyer B; Morace G; Roedger HJ; Roques C; Visa P; Steinhauer K
    Euro Surveill; 2021 Jan; 26(3):. PubMed ID: 33478622
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.